Insider buying at the PIPE price suggests management views the stock as undervalued. The PIPE provides balance sheet support, reducing near-term financing risk. Monitor for pipeline catalysts (phase updates) that could drive re-rating.
Price Chart
Executive Summary
Directors OrbiMed Advisors and Xu Diyong each purchased $10M of QTTB common stock at $8/share on May 28, 2026, for a total of $20M (10.1% of market cap). These open-market purchases coincide with a PIPE offering disclosed in the May 27 8-K, indicating insider participation and strong confidence at the offering price.
Key Financial Metrics
Key Facts
- OrbiMed Advisors LLC and Xu Diyong each bought 1,250,000 shares at $8.00 on 2026-05-28, total $20M.
- Total insider purchase equals ~10.1% of QTTB's $198M market cap.
- Purchases follow a Securities Purchase Agreement (8-K filed 2026-05-27) for a PIPE offering at the same $8 price.
- Both buyers are directors and 10% owners, amplifying the signal.
Financial Impact
Insiders invested $20M at $8/share, representing 10.1% of market cap; PIPE likely raises additional capital from other investors.
Risk Factors
- PIPE dilutes existing shareholders; new shares represent a significant overhang.
- Clinical-stage biotech risk; pipeline failure could impair recovery.
- Low historical win rate on score-6/7 reports for QTTB (calibration suggests caution).
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-QTTB-1780362955879 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | 8-K | $10.91 $10.47 | ▼ −4.03% | ▼ −4.14% | $8.23 (−24.56%) |
Aug 27, 2026 5w ago | Insider Cluster | $16.15 $12.80 | ▼ −20.74% | ▼ −21.01% | $8.23 (−49.04%) |
Aug 5, 2026 8w ago | 8-K | $16.49 $15.37 | ▼ −6.79% | ▼ −7.14% | $8.23 (−50.09%) |
Jul 15, 2026 11w ago | Press Release | $15.70 $15.08 | ▲ +3.95% | ▲ +2.97% | $8.23 (+47.58%) |
Jul 14, 2026 11w ago | EFFECT | $18.46 $15.04 | ▼ −18.53% | ▼ −17.23% | $8.23 (−55.42%) |
Jul 13, 2026 11w ago | 8-K | $21.38 $15.05 | ▼ −29.61% | ▼ −28.82% | $8.23 (−61.51%) |
Jul 13, 2026 11w ago | 8-K | $21.38 $15.05 | ▼ −29.61% | ▼ −28.82% | $8.23 (−61.51%) |
Jun 25, 2026 14w ago | S-3 | $13.17 $13.09 | ▼ −0.61% | ▼ −2.77% | $8.23 (−37.51%) |
Jun 2, 2026 17w ago | Insider Cluster | $12.64 $11.89 | ▼ −5.93% | ▼ −2.97% | $8.23 (−34.89%) |
May 5, 2026 21w ago | 8-K | $5.14 $5.81 | ▲ +13.04% | ▲ +11.05% | $8.23 (+60.12%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access